I prodotti di alcuni dei nostri fornitori non vengono visualizzati nei risultati della ricerca filtrata. Si prega di
deselezionare tutti i filtri
per vedere questi prodotti.
The COVID-19 Antigen Rapid Test (Rapid SARS-CoV-2 Antigen Test Card) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present in human nasal, nasopharyngeal, or oropharyngeal specimens.
Fisher Scientific Edge Gli ordini eseguiti prima delle 14:00 saranno spediti oggi stesso. Gli ordini eseguiti dopo le 14:00 saranno spediti domani. Per saperne di più
Maintain viability of viruses chlamydiae, mycoplasma and urealasma with top quality transport and storage media that comes in four versatile formulations.
Rapid 2019-nCoV IgG/IgM Combo Diagnostic Test Cards to COVID-19 è un test immunocromatografico rapido progettato per la determinazione qualitativa degli anticorpi IgG e IgM contro il nuovo coronavirus del 2019 (2019-nCoV, SARS-CoV-2) in siero umano, plasma o sangue intero.
SARS-CoV-2 Proteome Microarray with 4,883 virus specific peptides printed in duplicate. The microarray can be used for epitope mapping, serum screening, or biomarker discovery.
Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses, chlamydiae, mycoplasma and ureaplasma with top quality media from the experts in media.
Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses, chlamydiae, mycoplasma and ureaplasma with top quality media from the experts in media.
Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses, chlamydiae, mycoplasma and ureaplasma with top quality media from the experts in media.
Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses chlamydiae, mycoplasma and ureaplasma with quality media, proven collection and transport tools, and safe, reliable packaging.
For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.